Moderna chief executive sees pandemic over in a year: newspaper


Bancel said that Moderna's booster shot had half the dose of the original dose, which meant more of them would be available.- SCREENGRAB

ZURICH (Reuters): Moderna Inc Chief Executive Stéphane Bancel thinks the coronavirus pandemic could be over in a year as increased vaccine production ensures global supplies, he told the Swiss newspaper Neue Zuercher Zeitung.

"If you look at the industry-wide expansion of production capacities over the past six months, enough doses should be available by the middle of next year so that everyone on this earth can be vaccinated. Boosters should also be possible to the extent required," he told the newspaper in an interview.

Vaccinations would soon be available even for infants, he said.

"Those who do not get vaccinated will immunize themselves naturally, because the Delta variant is so contagious. In this way we will end up in a situation similar to that of the flu. You can either get vaccinated and have a good winter. Or you don't do it and risk getting sick and possibly even ending up in hospital."

Asked if that meant a return to normal in the second half of next year, he said: "As of today, in a year, I assume."

Bancel said he expected governments to approve booster shots for people already vaccinated because patients at risk who were vaccinated last autumn "undoubtedly" needed a refresher.

Its booster shot had half the dose of the original dose, which meant more of them would be available.

"The volume of vaccine is the biggest limiting factor. With half the dose, we would have 3 billion doses available worldwide for the coming year instead of just 2 billion," he said.

The composition of the booster shot remains the same as the original for this year because Moderna had not had enough time to change it.

"We are currently testing Delta-optimized variants in clinical trials. They will form the basis for the booster vaccination for 2022. We are also trying out Delta plus Beta, the next mutation that scientists believe is likely."

Moderna can use existing production lines for the new variants as for the original Covid-19 vaccine. The price of vaccination will stay the same, he said.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Moderna , vaccine , Stéphane Bancel

   

Next In Aseanplus News

Asean News Headlines at 10pm on Friday (Oct 15)
Singapore reports eight more Covid-19 deaths, 3,445 new infections on Saturday (Oct 15)
Indonesia reports 915 newly-confirmed Covid-19 cases, 41 more deaths as virus issues comes under control in country
Thailand recorded 10,486 Covid-19 cases and 94 deaths on Friday (Oct 15); govt easing virus measures
Philippines logs 7,625 new Covid-19 cases, total tops 2.7 million as country looks at reopening again
Vietnam's Covid-19 issues under control as govt reports 3,797 new Covid-19 cases - 857,639 in total on Saturday (Oct 15)
Asean's Myanmar meeting ends, to announce outcome on Saturday (Oct 16)
Singapore home sales drop for second month amid new virus curbs
Emerging Markets: Bank Indonesia to hold rates until late 2022 as Thai baht emerge as top weekly earner
Thailand to ramp up vaccination in four southern provinces to contain Covid-19

Others Also Read


Vouchers